معرفی
Su Golder is an Associate Professor in the Department of Health Sciences at the University of York, specializing in systematic review methodology and adverse effects research. With over 25 years' experience as an information specialist, she has pioneered the use of social media and text mining for pharmacovigilance. Her MRC-funded PhD and subsequent NIHR postdoctoral fellowship established her expertise in adverse effects information retrieval.
- PhD, Department of Health Sciences, University of York
- MSc, Information School, University of Sheffield
- BSc (Hons), Department of Human and Health Sciences, University of Huddersfield
Research Interests focus on information retrieval, systematic reviews, methodology development, and leveraging unconventional data sources like social media for adverse effects monitoring. Her recent work explores:
- Big data analytics for sex-specific disease understanding
- Network meta-analysis of HPV vaccination outcomes
- E-cigarette marketing analysis through social media
- Public perspectives on diabetes medications
- GP well-being during pandemic
- Alcohol industry influence on research
Scientific Contributions include:
- Developing search filters for adverse effects
- Co-founding Cochrane Adverse Effects Methods Group
- Delphi forum committee for PRESS guidelines
- InterTASC information specialists' group membership
- EAHIL (European Association for Health Information and Libraries)
Notable Projects funded by:
- NIH (Social Media Mining for Pharmacovigilance)
- NIHR (Opioid tapering evaluation)
- Cochrane Methods Innovation Fund (Harms data quality assessment)
- Yale University ODA initiative (rhBMP-2 safety review)
- MRC (Adverse effects retrieval optimization)
External Activities include:
- Invited keynote speaker at Pharma-Bio-Med conferences
- Member of PRISMA Harms Extension Steering Group
- Consultant for NICE information retrieval standards
- Peer reviewer for multiple journals
